Cited by 587

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

NARC-1/PCSK9 and Its Natural Mutants

Benjannet, Suzanne, Rhainds, David, Essalmani, Rachid, Mayne, Janice, Wickham, Louise, Jin, Weijun, Asselin, Marie-Claude, Hamelin, Josée, Varret, Mathilde, Allard, Delphine, Trillard, Mélanie, Abifadel, Marianne, Tebon, Angie, Attie, Alan D., Rader, Daniel J., Boileau, Catherine, Brissette, Louise, Chrétien, Michel, Prat, Annik, Seidah, Nabil G.·2004·Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m409699200

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The proteolytic activity of PCSK9 requires a catalytic triad of Asp186, His226, and Ser386.

    “The proteolytic activity of PCSK9 requires a triad of residues (Asp 186, His 226 and Ser 386), which constitute the 'catalytic triad' of the protease.”

    From PCSK9 is required for the disposal of non-acetylated intermediates of the nascent membrane protein BACE1 (2008) · cites this paper as Benjannet et al, 2004

    The Fig. 1 caption (page unavailable) identifies Asp, His, and Ser as PCSK9 active-site residues. The zymogen-processing results identify H226A as an active-site mutant that is not cleaved. Our copy does not identify the other two residues as Asp186 and Ser386 or establish that all three specified positions are required for proteolytic activity. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • PCSK9 is synthesized as an approximately 75 kDa proprotein (proPCSK9, P-form), and its N-terminal prodomain is removed by autocatalysis generating an approximately 65 kDa C-form that is secreted.

    “PCSK9 is synthesized as an approximately 75 kDa proprotein (proPCSK9, P-form); the N-terminal prodomain is then removed by autocatalysis (Seidah et al, 2003;Benjannet et al, 2004) generating an approximately 65 kDa form (C-form) that is secreted into the extracellular milieu (Grozdanov et al, 2006).”
  • Mutation of one residue of the PCSK9 catalytic triad abolishes its proteolytic activity and its ability to undergo processing to the C-form.

    “Mutation of one of these residues abolishes the proteolytic activity of PCSK9 and its ability to undergo processing to the C-form (Benjannet et al, 2004(Benjannet et al, , 2006;;McNutt et al, 2007).”
  • PCSK9 is synthesized as a proprotein zymogen in the ER that undergoes intramolecular autocatalytic cleavage to release the mature protein for transport out of the ER and for secretion.

    “PCSK9 is synthesized as a proprotein zymogen in the ER that undergoes intramolecular autocatalytic cleavage to release the mature protein for transport out of the ER and for secretion115–117.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 60

  1. Seidah, 1999, Brain Res., 848, 45, 10.1016/S0006-8993(99)01909-5 · DOI
  2. Zhou, 1999, J. Biol. Chem., 274, 20745, 10.1074/jbc.274.30.20745 · DOI
  3. Seidah, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 1321, 10.1073/pnas.96.4.1321 · DOI
  4. Sakai, 1998, Mol. Cell, 2, 505, 10.1016/S1097-2765(00)80150-1 · DOI
  5. Seidah, 2003, Proc. Natl. Acad. Sci. U. S. A., 100, 928, 10.1073/pnas.0335507100 · DOI · Paper page
  6. Seidah, 2002, Essays Biochem., 38, 79, 10.1042/bse0380079 · DOI
  7. Thomas, 2002, Nat. Rev. Mol. Cell. Biol., 3, 753, 10.1038/nrm934 · DOI
  8. Taylor, 2003, FASEB J., 17, 1215, 10.1096/fj.02-0831rev · DOI
  9. Roebroek, 1998, Development (Camb.), 125, 4863, 10.1242/dev.125.24.4863 · DOI
  10. Yang, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 13607, 10.1073/pnas.201524598 · DOI · Paper page
  11. Naureckiene, 2003, Arch. Biochem. Biophys., 420, 55, 10.1016/j.abb.2003.09.011 · DOI
  12. Jackson, 1997, Nat. Genet., 16, 303, 10.1038/ng0797-303 · DOI · Paper page
  13. Jackson, 2003, J. Clin. Investig., 112, 1550, 10.1172/JCI200318784 · DOI
  14. Abifadel, 2003, Nat. Genet., 34, 154, 10.1038/ng1161 · DOI · Paper page
  15. Rader, 2003, J. Clin. Investig., 111, 1795, 10.1172/JCI200318925 · DOI · Paper page
  16. Timms, 2004, Hum. Genet., 114, 349, 10.1007/s00439-003-1071-9 · DOI
  17. Leren, 2004, Clin. Genet., 65, 419, 10.1111/j.0009-9163.2004.0238.x · DOI
  18. Shioji, 2004, J. Hum. Genet., 49, 109, 10.1007/s10038-003-0114-3 · DOI
  19. Horton, 2003, Proc. Natl. Acad. Sci. U. S. A., 100, 12027, 10.1073/pnas.1534923100 · DOI · Paper page
  20. Maxwell, 2003, J. Lipid Res., 44, 2109, 10.1194/jlr.M300203-JLR200 · DOI · Paper page
  21. Dubuc, 2004, Arterioscler. Thromb. Vasc. Biol., 24, 1454, 10.1161/01.ATV.0000134621.14315.43 · DOI · Paper page
  22. Sakai, 1998, J. Biol. Chem., 273, 5785, 10.1074/jbc.273.10.5785 · DOI
  23. Brown, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 11041, 10.1073/pnas.96.20.11041 · DOI · Paper page
  24. Bergeron, 2003, Biochem. J., 373, 475, 10.1042/bj20021630 · DOI
  25. Conesa, 2003, Biochem. J., 370, 703, 10.1042/bj20021301 · DOI
  26. Benjannet, 2001, J. Biol. Chem., 276, 10879, 10.1074/jbc.M009899200 · DOI · Paper page
  27. Louie, 1991, Am. J. Hum. Genet., 48, 637
  28. Goldstein, 1983, Methods Enzymol., 98, 241, 10.1016/0076-6879(83)98152-1 · DOI
  29. Yoshimura, 1987, J. Biol. Chem., 262, 13299, 10.1016/S0021-9258(18)45201-5 · DOI
  30. Hatch, 1968, Adv. Lipid Res., 6, 1, 10.1016/B978-1-4831-9942-9.50008-5 · DOI
  31. Brissette, 1996, Biochem. J., 318, 841, 10.1042/bj3180841 · DOI
  32. Langer, 1972, J. Clin. Investig., 51, 1528, 10.1172/JCI106949 · DOI
  33. Lowry, 1951, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI
  34. Hopkins, 1983, J. Cell Biol., 97, 508, 10.1083/jcb.97.2.508 · DOI
  35. Jin, 2003, J. Clin. Investig., 111, 357, 10.1172/JCI16146 · DOI
  36. Gluschankof, 1994, EMBO J., 13, 2280, 10.1002/j.1460-2075.1994.tb06510.x · DOI
  37. Elagoz, 2002, J. Biol. Chem., 277, 11265, 10.1074/jbc.M109011200 · DOI · Paper page
  38. Reed, 1972, J. Biol. Chem., 247, 6970, 10.1016/S0021-9258(19)44681-4 · DOI
  39. Brayden, 1989, Br. J. Pharmacol., 98, 809, 10.1111/j.1476-5381.1989.tb14609.x · DOI
  40. Thyberg, 1985, Exp. Cell Res., 159, 1, 10.1016/S0014-4827(85)80032-X · DOI · Paper page
  41. Hortin, 1986, Biochem. Biophys. Res. Commun., 141, 326, 10.1016/S0006-291X(86)80372-2 · DOI
  42. Beisswanger, 1998, Proc. Natl. Acad. Sci. U. S. A., 95, 11134, 10.1073/pnas.95.19.11134 · DOI
  43. Ouguerrram, 2004, Arterioscler. Thromb. Vasc. Biol., 8, 1448, 10.1161/01.ATV.0000133684.77013.88 · DOI
  44. King-Underwood, 1991, Clin. Genet., 40, 17, 10.1111/j.1399-0004.1991.tb03064.x · DOI
  45. Gekle, 1995, Am. J. Physiol., 268, F899
  46. Kopfler, 1994, Circulation, 90, 1319, 10.1161/01.CIR.90.3.1319 · DOI
  47. Krieger, 1983, Cell, 33, 413, 10.1016/0092-8674(83)90423-3 · DOI
  48. Henrich, 2003, Nat. Struct. Biol., 10, 520, 10.1038/nsb941 · DOI
  49. Zhou, 1998, J. Biol. Chem., 273, 11107, 10.1074/jbc.273.18.11107 · DOI
  50. Benjannet, 1993, Biochem. J., 294, 735, 10.1042/bj2940735 · DOI
  51. De Bie, 1996, J. Cell Biol., 135, 1261, 10.1083/jcb.135.5.1261 · DOI
  52. Gregersen, 2001, J. Inherited Metab. Dis., 24, 189, 10.1023/A:1010319001722 · DOI
  53. Siezen, 1997, Protein Sci., 6, 501, 10.1002/pro.5560060301 · DOI · Paper page
  54. Soutar, 1992, J. Intern. Med., 231, 633, 10.1111/j.1365-2796.1992.tb01252.x · DOI
  55. Kunst, 1997, Nat. Genet., 15, 91, 10.1038/ng0197-91 · DOI
  56. Twisk, 2000, J. Clin. Investig., 105, 521, 10.1172/JCI8623 · DOI
  57. Tremblay, 2004, J. Lipid Res., 45, 866, 10.1194/jlr.M300448-JLR200 · DOI
  58. Wang, 1997, J. Biol. Chem., 272, 27644, 10.1074/jbc.272.44.27644 · DOI
  59. Maxwell, 2004, Proc. Natl. Acad. Sci. U. S. A., 101, 7100, 10.1073/pnas.0402133101 · DOI · Paper page
  60. Varret, 1999, Am. J. Hum. Genet., 64, 1378, 10.1086/302370 · DOI

Cited by

Sorted by citations

Metadata

Authors
Benjannet, S., Rhainds, D., Essalmani, R., Mayne, J., Wickham, L., Jin, W., Asselin, M.-C., Hamelin, J., Varret, M., Allard, D., Trillard, M., Abifadel, M., Tebon, A., Attie, A. D., Rader, D. J., Boileau, C., Brissette, L., Chrétien, M., Prat, A., & Seidah, N. G.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-11
Volume
279
Issue
47
Pages
48865-48875
ISSN
0021-9258
Cited by
587
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review